Lockshin Curtis 4
4 · Xenetic Biosciences, Inc. · Filed Dec 6, 2019
Insider Transaction Report
Form 4
Lockshin Curtis
Chief Scientific Officer
Transactions
- Award
Stock Options
2019-12-04+90,000→ 90,000 totalExercise: $1.31Exp: 2029-12-04→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]The shares underlying the options will vest and become exercisable as follows: 30,000 shares shall vest on the first anniversary of December 4, 2019 ("Vesting Start Date"); 30,000 shares shall vest on the second anniversary of the Vesting Start Date; and 30,000 shares shall vest on the third anniversary of the Vesting Start Date.